OncoSil™ (originally called BrachySil™) is a 32P-loaded microparticle developed for the treatment of pancreatic cancer. In April 2020, OncoSil obtained European CE marking approval as a brachytherapy device to treat locally advanced pancreatic cancer in combination with chemotherapy, clearing the way for marketing in both the EU and the U.K.
Radiotherapeutics
P-32-OncoSil

- Target/Mechanism
- Brachytherapy
- Carrier/Ligand
- n/a
- Radiation Type
- beta (β–)